0001127602-17-014039.txt : 20170404
0001127602-17-014039.hdr.sgml : 20170404
20170404172857
ACCESSION NUMBER: 0001127602-17-014039
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170403
FILED AS OF DATE: 20170404
DATE AS OF CHANGE: 20170404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alkermes plc.
CENTRAL INDEX KEY: 0001520262
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981007018
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CONNAUGHT HOUSE
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN 4
STATE: L2
ZIP: 00000
BUSINESS PHONE: 00-353-1-772-8000
MAIL ADDRESS:
STREET 1: CONNAUGHT HOUSE
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN 4
STATE: L2
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC
DATE OF NAME CHANGE: 20110804
FORMER COMPANY:
FORMER CONFORMED NAME: Antler Science Two Ltd
DATE OF NAME CHANGE: 20110509
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BIBERSTEIN KATHRYN L
CENTRAL INDEX KEY: 0001235595
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35299
FILM NUMBER: 17739790
MAIL ADDRESS:
STREET 1: 88 SIDNEY ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 021394136
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2017-04-03
0001520262
Alkermes plc.
ALKS
0001235595
BIBERSTEIN KATHRYN L
852 WINTER ST.
WALTHAM
MA
02451
1
EVP/CAO/CCO Alks Inc; Sec ALKS
Ordinary Shares
2017-04-03
4
M
0
15000
15.95
A
69904
D
Ordinary Shares
2017-04-03
4
S
0
10937
57.4114
D
58967
D
Ordinary Shares
2017-04-03
4
S
0
3763
58.3544
D
55204
D
Ordinary Shares
2017-04-03
4
S
0
300
59.125
D
54904
D
Ordinary Shares
36848
I
By 2015 GRAT
Ordinary Shares
57152
I
By 2016 GRAT
Non Qualified Stock Option (Right to Buy)
15.95
2017-04-03
4
M
0
15000
0
D
2017-06-01
Ordinary Shares
15000
0
D
This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $57.04 to $58.03. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $58.05 to $59.01. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $59.05 to $59.18. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Shares held by the 2015 GRAT. The Reporting Person is a trustee and beneficiary of the 2015 GRAT and may be deemed to hold voting and dispositive power with regard to the reported shares held by the 2015 GRAT.
Shares held by the 2016 GRAT. The Reporting Person is a trustee and beneficiary of the 2016 GRAT and may be deemed to hold voting and dispositive power with regard to the reported shares held by the 2016 GRAT.
These options are fully vested in accordance with their terms.
/s/ Jennifer Baptiste, attorney-in-fact for Kathryn L. Biberstein
2017-04-04